Sutro Biopharma Inc (STRO) is near the top in its industry group according to InvestorsObserver. STRO gets an overall rating of 65. That means it scores higher than 65 percent of stocks. Sutro Biopharma Inc gets a 76 rank in the Biotechnology industry. Biotechnology is number 17 out of 148 industries.
STRO has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on STRO!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 65 means the stock is more attractive than 65 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Sutro Biopharma Inc Stock Today?
Sutro Biopharma Inc (STRO) stock is up 7.16% while the S&P 500 is lower by -0.87% as of 1:16 PM on Tuesday, Feb 20. STRO has gained $0.31 from the previous closing price of $4.33 on volume of 298,872 shares. Over the past year the S&P 500 is up 24.13% while STRO is lower by -23.81%. STRO lost -$2.91 per share the over the last 12 months.
Click Here to get the full Stock Report for Sutro Biopharma Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
